Treatment outcomes and associated factors among patients with drug-sensitive tuberculosis on daily fixed-dose combination drugs: A cohort study from Ahmedabad, India.

Prajapati, Arpit C; Shah, Tejas; Panchal, Sagar; Joshi, Bhavin; Shringarpure, Kalpita; Jakasania, Arjunkumar; Kathirvel, Soundappan

Prajapati, Arpit C; Shah, Tejas; Panchal, Sagar; Joshi, Bhavin; Shringarpure, Kalpita; Jakasania, Arjunkumar; Kathirvel, Soundappan.

Prajapati AC; Department of Community Medicine, GCS Medical College, Hospital and Research Centre, Ahmedabad, Gujarat, India.
Shah T; City TB Officer, Health Department, Ahmedabad Municipal Corporation, Ahmedabad, Gujarat, India.
Panchal S; Medical Officer, District Tuberculosis Centre, Ahmedabad Municipal Corporation, Ahmedabad, Gujarat, India.
Joshi B; Additional Medical Officer of Health, Health Department, Ahmedabad Municipal Corporation, Ahmedabad, Gujarat, India.
Shringarpure K; Community Medicine Department, Medical College, Baroda, Gujarat, India.
Jakasania A; Community Medicine Department, MGIMS, Sewagram, Wardha, Maharashtra, India.
Kathirvel S; Department of Community Medicine and School of Public Health, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

J Family Med Prim Care ; 12(3): 452-459, 2023 Mar.

Article en En | MEDLINE | ID: mdl-37122671

Palabras clave

Drug-sensitive TB; HIV; fixed-dose combination; successful; treatment outcome

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google